InvestSMART

Telix Pharmaceuticals Limited (ASX: TLX) - Announcements

Current share price for TLX : $15.900 0.16 (1.02%)+

ASX company news and announcements for Telix Pharmaceuticals Limited (TLX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Telix Pharmaceuticals Limited (TLX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Telix Pharmaceuticals Limited (TLX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Telix Pharmaceuticals Limited (TLX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5,404 Cleansing Notice 10 Nov 2023 8:19AM $9.570 $15.900 risen by 66.14%
$5,404 Application for quotation of securities - TLX 10 Nov 2023 8:19AM $9.570 $15.900 risen by 66.14%
$5,404 Notification regarding unquoted securities - TLX 2 Nov 2023 8:21AM $8.980 $15.900 risen by 77.06%
$5,404 Cleansing Notice 2 Nov 2023 8:18AM $8.980 $15.900 risen by 77.06%
$5,404 Application for quotation of securities - TLX 2 Nov 2023 8:18AM $8.980 $15.900 risen by 77.06%
$5,404 Telix Completes Acquisition of Lightpoint Medical 1 Nov 2023 7:26PM $8.980 $15.900 risen by 77.06%
$5,404 ProstACT SELECT Study of TLX591 Positive Interim Readout 19 Oct 2023 8:18AM $10.230 $15.900 risen by 55.43%
$5,404 Q3 2023 Business Update to Accompany Quarterly Results 18 Oct 2023 4:44PM $10.230 $15.900 risen by 55.43%
$5,404 Activities Report and Appendix 4C - September 2023 Quarter 18 Oct 2023 4:42PM $10.230 $15.900 risen by 55.43%
$5,404 Notification of cessation of securities - TLX 13 Oct 2023 8:24AM $11.300 $15.900 risen by 40.71%
$5,404 Cleansing Notice 13 Oct 2023 8:21AM $11.300 $15.900 risen by 40.71%
$5,404 Application for quotation of securities - TLX 13 Oct 2023 8:21AM $11.300 $15.900 risen by 40.71%
$5,404 Notification of upcoming quarterly results and investor call 11 Oct 2023 8:36AM $11.480 $15.900 risen by 38.50%
$5,404 Cleansing Notice 27 Sep 2023 8:20AM $11.320 $15.900 risen by 40.46%
$5,404 Application for quotation of securities - TLX 27 Sep 2023 8:20AM $11.320 $15.900 risen by 40.46%
$5,404 Cleansing Notice 6 Sep 2023 8:20AM $10.780 $15.900 risen by 47.50%
$5,404 Application for quotation of securities - TLX 6 Sep 2023 8:19AM $10.780 $15.900 risen by 47.50%
$5,404 1H 2023 Results Presentation 23 Aug 2023 6:45PM $9.790 $15.900 risen by 62.41%
$5,404 1H 2023 Results Release 23 Aug 2023 6:44PM $9.790 $15.900 risen by 62.41%
$5,404 1H 2023 Appendix 4D and Interim Report 23 Aug 2023 6:44PM $9.790 $15.900 risen by 62.41%
$5,404 Cleansing Notice 16 Aug 2023 8:18AM $10.180 $15.900 risen by 56.19%
$5,404 Application for quotation of securities - TLX 16 Aug 2023 8:18AM $10.180 $15.900 risen by 56.19%
$5,404 Telix Half Year Results and Investor Conference Call Details 15 Aug 2023 8:05AM $9.970 $15.900 risen by 59.48%
$5,404 First Patient Dosed in Phase 3 Illuccix China Study 11 Aug 2023 9:05AM $10.110 $15.900 risen by 57.27%
$5,404 Cleansing Notice 27 Jul 2023 8:21AM $11.110 $15.900 risen by 43.11%

376 - 400 of 961 results

Page 16 of 39

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.